1,851
Views
10
CrossRef citations to date
0
Altmetric
Oncology

High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer

, , , , , , & ORCID Icon show all
Pages 2178-2193 | Received 15 Jul 2021, Accepted 26 Oct 2021, Published online: 16 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kaiyue Ding, Minhan Yi, Hui Liang, Zhongkui Li & Yuan Zhang. (2022) Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression. Expert Review of Clinical Immunology 18:7, pages 759-771.
Read now

Articles from other publishers (9)

Shuoyi Yao, Bin Liu, Xinyue Hu, Yun Tan, Kun Liu, Meng He, Bohan Wu, Namra Ahmad, Xiaoli Su, Minhan Yi & Yuan Zhang. (2024) Diagnostic Value of MicroRNAs in Active Tuberculosis based on Meta-analysis and Enrichment Analyses. Diagnostic Microbiology and Infectious Disease, pages 116172.
Crossref
Débora Dummer Meira, Maria Clara de Castro e Caetano, Matheus Correia Casotti, Aléxia Stefani Siqueira Zetum, André Felipe Monteiro Gonçalves, André Rodrigues Moreira, Augusto Henrique de Oliveira, Fellipe Pesente, Gabriel Mendonça Santana, Daniel de Almeida Duque, Gierleson Santos Cangussu Pereira, Giulia de Souza Cupertino de Castro, Isabele Pagani Pavan, João Pedro Sarcinelli Chagas, José Henrique Borges Bourguignon, Juliana Ribeiro de Oliveira, Karen Ruth Michio Barbosa, Lorena Souza Castro Altoé, Luana Santos Louro, Luiza Poppe Merigueti, Lyvia Neves Rebello Alves, Marlon Ramos Rosado Machado, Maria Luísa Rodrigues Oliveira Roque, Pedro Santana Prates, Sayuri Honorio de Paula Segáua, Taissa dos Santos Uchiya, Thomas Erik Santos Louro, Vinicius Eduardo Daleprane, Yasmin Moreto Guaitolini, Creuza Rachel Vicente, Raquel Silva dos Reis Trabach, Bruno Cancian de Araújo, Eldamária de Vargas Wolfgramm dos Santos, Flávia de Paula, Tiago José S. Lopes, Elizeu Fagundes de Carvalho & Iúri Drumond Louro. (2023) Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. Genes 14:10, pages 1906.
Crossref
Yaoguo Lang, Xianglong Kong, Benkun Liu, Xiangyuan Jin, Lantao Chen & Shidong Xu. (2023) microRNA‐651‐5p affects the proliferation, migration, and invasion of lung cancer cells by regulating Calmodulin 2 expression. The Clinical Respiratory Journal 17:8, pages 754-763.
Crossref
M. Yu. Konoshenko, P. P. Laktionov, Yu. A. Lancuhaj, S. V. Pak, S. E. Krasilnikov & O. E. Bryzgunova. (2023) Cell-free plasma miRNAs analysis for low invasive lung cancer diagnostics. Advances in Molecular Oncology 10:2, pages 78-89.
Crossref
William C. Cho, Chi F. Wong, Kwan P. Li, Alvin H. Fong, King Y. Fung & Joseph S. Au. (2023) miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 24:12, pages 10022.
Crossref
Bing Dong, Xiaowei Liu, Su Wang, Xiujun Chen, Kun Zhang & Yan Zhang. (2023) microRNA-125a-5p as a Tumor Suppressor in Non-Small Cell Lung Cancer (NSCLC): Inhibition of Proliferation and Induction of Apoptosis via P13K/AKT/MMP Signaling Pathway. Science of Advanced Materials 15:4, pages 544-550.
Crossref
Xi Zhao & Salam Pradeep Si. (2022) Biological Evaluation of Chinese Herbal Compounds as Anticancer Agents in Fighting Against Lung Cancer. International Journal of Pharmacology 18:6, pages 1244-1251.
Crossref
Beata Smolarz, Adam Durczyński, Hanna Romanowicz, Krzysztof Szyłło & Piotr Hogendorf. (2022) miRNAs in Cancer (Review of Literature). International Journal of Molecular Sciences 23:5, pages 2805.
Crossref
Karolina Henryka Czarnecka-Chrebelska & Ewa Brzeziańska-Lasota. 2022.